Absolute Risk Prediction for Cannabis Use Disorder in Adolescence and Early Adulthood Using Bayesian Machine Learning
- URL: http://arxiv.org/abs/2501.09156v2
- Date: Tue, 27 May 2025 20:57:38 GMT
- Title: Absolute Risk Prediction for Cannabis Use Disorder in Adolescence and Early Adulthood Using Bayesian Machine Learning
- Abstract summary: We developed a novel absolute risk prediction model for cannabis use disorder (CUD) for adolescents or young adults who use cannabis.<n>The proposed model has five risk factors: biological sex, delinquency, and scores on personality traits of conscientiousness, neuroticism, and openness.
- Score: 0.0
- License: http://creativecommons.org/licenses/by-nc-nd/4.0/
- Abstract: Introduction: Substance use disorders (SUDs) have emerged as a pressing public health concern in the United States, with adolescent substance use often leading to SUDs in adulthood. Effective strategies are needed to stem this progression. To help fulfill this need, we developed a novel absolute risk prediction model for cannabis use disorder (CUD) for adolescents or young adults who use cannabis. Methods: We trained a Bayesian machine learning model that provides a personalized CUD absolute risk for adolescents or young adults who use cannabis with data from the National Longitudinal Study of Adolescent to Adult Health. Model performance was assessed using 5-fold cross-validation (CV) with area under the curve (AUC) and ratio of the expected to observed number of cases (E/O). Independent validation of the final model was conducted using two datasets. Results: The proposed model has five risk factors: biological sex, delinquency, and scores on personality traits of conscientiousness, neuroticism, and openness. For predicting CUD risk within five years of first cannabis use, AUC values for the training dataset and two validation datasets were 0.68, 0.64, and 0.75, respectively, and E/O values were 0.95, 0.98, and 1, respectively. This indicates good discrimination and calibration performance of the model. Discussion and Conclusion: The proposed model can aid clinicians in assessing the risk of developing CUD among adolescents and young adults who use cannabis, enabling clinically appropriate interventions.
Related papers
- ASD-Bench: A Four-Axis Comprehensive Benchmark of AI Models for Autism Spectrum Disorder [0.0]
ASD-Bench is a systematic benchmark evaluating ML, deep learning, and foundation model configurations across three age cohorts.<n> applied to a curated v3 dataset of 4,068 AQ-10 records.<n>Adult classification yields high performance (10/17 models achieve perfect F1 and AUC), while adolescents present a harder task (F1 ceiling 0.837 vs. 0.915 for children)
arXiv Detail & Related papers (2026-05-11T18:01:21Z) - Child Mortality Prediction in Bangladesh: A Decade-Long Validation Study [0.0]
The Demographic and Health Surveys (DHS) data from Bangladesh for 2011-2022, with n = 33,962, are used in this paper.<n>We trained the model on (2011-2014) data, validated it on 2017 data, and tested it on 2022 data.<n>Eight years after the initial test of the model, a genetic algorithm-based Neural Architecture Search found a single-layer neural architecture to be superior to XGBoost.
arXiv Detail & Related papers (2026-02-03T19:18:50Z) - Explainable Admission-Level Predictive Modeling for Prolonged Hospital Stay in Elderly Populations: Challenges in Low- and Middle-Income Countries [65.4286079244589]
Prolonged length of stay (pLoS) is a significant factor associated with the risk of adverse in-hospital events.<n>We develop and explain a predictive model for pLos using admission-level patient and hospital administrative data.
arXiv Detail & Related papers (2026-01-07T23:35:24Z) - Modeling Novel Oral Nicotine Use Among Adolescents [0.0]
Among U.S. high school students, nicotine pouch use has doubled since 2021, with 2.4% reporting current use in 2024.<n>We analyzed Florida Youth Tobacco Survey data from 2022-2024 to assess prevalence trends.<n>We developed a grade-structured compartmental model to project future trajectories and evaluate intervention strategies.
arXiv Detail & Related papers (2025-11-14T14:07:33Z) - Assessing the robustness of heterogeneous treatment effects in survival analysis under informative censoring [50.164756034797136]
Dropout is common in clinical studies, with up to half of patients leaving early due to side effects or other reasons.<n>When dropout is informative, it introduces censoring bias, because of which treatment effect estimates are also biased.<n>We propose an assumption-lean framework to assess the robustness of conditional average treatment effect estimates in survival analysis when facing censoring bias.
arXiv Detail & Related papers (2025-10-15T10:51:17Z) - Interpretable Graph-Language Modeling for Detecting Youth Illicit Drug Use [51.696842592898804]
Illicit drug use among teenagers and young adults (TYAs) remains a pressing public health concern.<n>To detect illicit drug use among TYAs, researchers analyze large-scale surveys such as the Youth Risk Behavior Survey (YRBS) and the National Survey on Drug Use and Health (NSDUH)<n>Existing modeling methods treat survey variables independently, overlooking latent and interconnected structures among them.<n>We propose LAMI, a novel joint graph-language modeling framework for detecting illicit drug use and interpreting behavioral risk factors among TYAs.
arXiv Detail & Related papers (2025-10-11T17:29:50Z) - Adaptable Cardiovascular Disease Risk Prediction from Heterogeneous Data using Large Language Models [70.64969663547703]
AdaCVD is an adaptable CVD risk prediction framework built on large language models extensively fine-tuned on over half a million participants from the UK Biobank.<n>It addresses key clinical challenges across three dimensions: it flexibly incorporates comprehensive yet variable patient information; it seamlessly integrates both structured data and unstructured text; and it rapidly adapts to new patient populations using minimal additional data.
arXiv Detail & Related papers (2025-05-30T14:42:02Z) - Development and Validation of a Deep-Learning Model for Differential Treatment Benefit Prediction for Adults with Major Depressive Disorder Deployed in the Artificial Intelligence in Depression Medication Enhancement (AIDME) Study [0.622895724042048]
The pharmacological treatment of Major Depressive Disorder (MDD) relies on a trial-and-error approach.<n>We introduce an artificial intelligence (AI) model aiming to personalize treatment outcomes.
arXiv Detail & Related papers (2024-06-07T15:04:59Z) - Using Pre-training and Interaction Modeling for ancestry-specific disease prediction in UK Biobank [69.90493129893112]
Recent genome-wide association studies (GWAS) have uncovered the genetic basis of complex traits, but show an under-representation of non-European descent individuals.
Here, we assess whether we can improve disease prediction across diverse ancestries using multiomic data.
arXiv Detail & Related papers (2024-04-26T16:39:50Z) - Towards Clinical Prediction with Transparency: An Explainable AI
Approach to Survival Modelling in Residential Aged Care [0.0]
The study applies machine learning to create a survival model for aged care, aligning with clinical insights on mortality risk factors.
Key mortality predictors include age, male gender, mobility, health status, pressure ulcer risk, and appetite.
arXiv Detail & Related papers (2023-12-01T01:11:16Z) - MedDiffusion: Boosting Health Risk Prediction via Diffusion-based Data
Augmentation [58.93221876843639]
This paper introduces a novel, end-to-end diffusion-based risk prediction model, named MedDiffusion.
It enhances risk prediction performance by creating synthetic patient data during training to enlarge sample space.
It discerns hidden relationships between patient visits using a step-wise attention mechanism, enabling the model to automatically retain the most vital information for generating high-quality data.
arXiv Detail & Related papers (2023-10-04T01:36:30Z) - Adapting Machine Learning Diagnostic Models to New Populations Using a Small Amount of Data: Results from Clinical Neuroscience [21.420302408947194]
We develop a weighted empirical risk minimization approach that optimally combines data from a source group to make predictions on a target group.
We apply this method to multi-source data of 15,363 individuals from 20 neuroimaging studies to build ML models for diagnosis of Alzheimer's disease and estimation of brain age.
arXiv Detail & Related papers (2023-08-06T18:05:39Z) - Diagnosis Uncertain Models For Medical Risk Prediction [80.07192791931533]
We consider a patient risk model which has access to vital signs, lab values, and prior history but does not have access to a patient's diagnosis.
We show that such all-cause' risk models have good generalization across diagnoses but have a predictable failure mode.
We propose a fix for this problem by explicitly modeling the uncertainty in risk prediction coming from uncertainty in patient diagnoses.
arXiv Detail & Related papers (2023-06-29T23:36:04Z) - Drug Synergistic Combinations Predictions via Large-Scale Pre-Training
and Graph Structure Learning [82.93806087715507]
Drug combination therapy is a well-established strategy for disease treatment with better effectiveness and less safety degradation.
Deep learning models have emerged as an efficient way to discover synergistic combinations.
Our framework achieves state-of-the-art results in comparison with other deep learning-based methods.
arXiv Detail & Related papers (2023-01-14T15:07:43Z) - Learning Clinical Concepts for Predicting Risk of Progression to Severe
COVID-19 [17.781861866125023]
Using data from a major healthcare provider, we develop survival models predicting severe COVID-19 progression.
We develop two sets of high-performance risk scores: (i) an unconstrained model built from all available features; and (ii) a pipeline that learns a small set of clinical concepts before training a risk predictor.
arXiv Detail & Related papers (2022-08-28T02:59:35Z) - A New Approach for Interpretability and Reliability in Clinical Risk
Prediction: Acute Coronary Syndrome Scenario [0.33927193323747895]
We intend to create a new risk assessment methodology that combines the best characteristics of both risk score and machine learning models.
The proposed approach achieved testing results identical to the standard LR, but offers superior interpretability and personalization.
The reliability estimation of individual predictions presented a great correlation with the misclassifications rate.
arXiv Detail & Related papers (2021-10-15T19:33:46Z) - Development of a dynamic type 2 diabetes risk prediction tool: a UK
Biobank study [0.8620335948752806]
We developed a predictive 10-year type 2 diabetes risk score using 301 features from the UK Biobank dataset.
A Cox proportional hazards model slightly overperformed a DeepSurv model trained using the same features.
This tool can be used for clinical screening of individuals at risk of developing type 2 diabetes and to foster patient empowerment.
arXiv Detail & Related papers (2021-04-20T16:37:26Z) - Development of an accessible 10-year Digital CArdioVAscular (DiCAVA)
risk assessment: a UK Biobank study [0.46180371154032895]
The aim was to develop a new risk model (DiCAVA) using statistical and machine learning techniques.
A secondary goal was to identify new patient-centric variables that could be incorporated into CVD risk assessments.
arXiv Detail & Related papers (2021-04-20T16:01:50Z) - Bootstrapping Your Own Positive Sample: Contrastive Learning With
Electronic Health Record Data [62.29031007761901]
This paper proposes a novel contrastive regularized clinical classification model.
We introduce two unique positive sampling strategies specifically tailored for EHR data.
Our framework yields highly competitive experimental results in predicting the mortality risk on real-world COVID-19 EHR data.
arXiv Detail & Related papers (2021-04-07T06:02:04Z) - UNITE: Uncertainty-based Health Risk Prediction Leveraging Multi-sourced
Data [81.00385374948125]
We present UNcertaInTy-based hEalth risk prediction (UNITE) model.
UNITE provides accurate disease risk prediction and uncertainty estimation leveraging multi-sourced health data.
We evaluate UNITE on real-world disease risk prediction tasks: nonalcoholic fatty liver disease (NASH) and Alzheimer's disease (AD)
UNITE achieves up to 0.841 in F1 score for AD detection, up to 0.609 in PR-AUC for NASH detection, and outperforms various state-of-the-art baselines by up to $19%$ over the best baseline.
arXiv Detail & Related papers (2020-10-22T02:28:11Z) - Identifying Risk of Opioid Use Disorder for Patients Taking Opioid
Medications with Deep Learning [3.2663488776173573]
The U.S. is experiencing an opioid epidemic, and there were more than 10 million opioid misusers aged 12 or older each year.
Identifying patients at high risk of Opioid Use Disorder (OUD) can help to make early clinical interventions to reduce the risk of OUD.
Our goal is to predict OUD patients among opioid prescription users through analyzing electronic health records with machine learning and deep learning methods.
arXiv Detail & Related papers (2020-10-09T14:18:07Z) - Robustness to Spurious Correlations via Human Annotations [100.63051542531171]
We present a framework for making models robust to spurious correlations by leveraging humans' common sense knowledge of causality.
Specifically, we use human annotation to augment each training example with a potential unmeasured variable.
We then introduce a new distributionally robust optimization objective over unmeasured variables (UV-DRO) to control the worst-case loss over possible test-time shifts.
arXiv Detail & Related papers (2020-07-13T20:05:19Z) - 1-D Convlutional Neural Networks for the Analysis of Pupil Size
Variations in Scotopic Conditions [79.71065005161566]
1-D convolutional neural network models are trained for classification of short-range sequences.
Model provides prediction with high average accuracy on a hold out test set.
arXiv Detail & Related papers (2020-02-06T17:25:37Z)
This list is automatically generated from the titles and abstracts of the papers in this site.
This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.